Studies on quinazolines X.1 Synthesis and pharmacological evaluation of 4(3H)-quinazolinone biphenyl tetrazoles as angiotensin II antagonists+

Chinese Pharmaceutical Journal

Volumn 51, Issue 1, 1999, Pages 31-48

  Chern, Ji Wang ^a   Lo, Jir Chun ^a   Lin, Hua Mei ^b   Cheng, Fong Chi ^c   Usifoh, Cyril O ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAO YUAN GENERAL HOSPITAL   (Taiwan)

^c Pharmacology Laboratories   (Taiwan)

Author keywords

Angiotensin II antagonist; Biphenyl tetrazole; Quinazolinone

Indexed keywords

1 [3,4 DIHYDRO 4 OXO 3 [[2' (TETRAZOL 5 YL)BIPHENYL 4 YL]METHYL] 2 QUINAZOLINYL] 4 PENTANONE; 2 BENZYL 3 [[2' (TETRAZOL 5 YL)BIPHENYL 4 YL]METHYL]QUINAZOLIN 4(3H) ONE; 2 PHENYL 3 [[2' (TETRAZOL 5 YL)BIPHENYL 4 YL]METHYL]QUINAZOLIN 4(3H) ONE; 3 [3,4 DIHYDRO 4 OXO 3 [[2' (TETRAZOL 5 YL)BIPHENYL 4 YL]METHYL] 2 QUINAZOLINYL]PROPIONIC ACID; 3,4 DIHYDRO 4 OXO 3 [[2' (TETRAZOL 5 YL)BIPHENYL 4 YL]METHYL]QUINAZOLINE 2 CARBOXYLIC ACID; 3,4 DIHYDRO 4 OXO 3 [[[2' (TETRAZOL 2 YL)BIPHENYL 4 YL]BIPHENYL 4 YL]METHYL]QUINAZOLINE 2 CARBOXAMIDE; 4 [3,4 DIHYDRO 4 OXO 3 [[2' (TETRAZOL 5 YL)BIPHENYL 4 YL]METHYL] 2 QUINAZOLINYL]BUTYRIC ACID; ALKANONE; AMIDE; ANGIOTENSIN II ANTAGONIST; ANGIOTENSIN RECEPTOR; BUTYRIC ACID; CARBOXYLIC ACID; ETHYL 3,4 DIHYDRO 4 OXO 3 [[2' (TETRAZOL 5 YL) 4 YL]METHYL]QUINAZOLINE 2 CARBOXYLIC ACID; LOSARTAN; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; PROPIONIC ACID; QUINAZOLINE DERIVATIVE; TETRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; FEMALE; HYDROPHOBICITY; LIPOPHILICITY; MALE; NONHUMAN; RABBIT;

EID: 0033049280     PISSN: 10161015     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Previous studies in this series: Chern, J.-W.; Chang, J.-Y.; Usifoh, C. O.; Gutsait, A. Studies on Quinazolines IX: Fluorination versus 1,2-Migration in the Reaction of 1,3-Bifunctionalized amino-2-propanol with DAST. Tetrahedron Lett. 1998, 46, 8483-8486.
2. Waeber, B.; Nussberger, J.; Brunner, H. R. Angiotensin-Converting Enzyme Inhibitors in Hypertension. PathoPhysiology, Diagnosis and Management; Laragh, J. H., Brenner, B. M. Eds.; Raven Press: New York, 1990; pp 2209-2232.
3. (a) Ferario, C. M. The Renin-Angiotensin System: Importance in Physiology and Pathology. J. Cardiovasc. Pharmacol. 1990, 15 (Suppl. 3), S1-S5.
4. (b) Vallotton, M. B. The Renin-Angiotensin System. Trends Pharmacol. Sci. 1987, 8, 69-74.
5. Johnston, C. I. Biochemistry and Pharmacology of the Renin-Angiotensin System. Drugs 1990, 39 (Suppl.), 21-31.
6. Lindgren, B. R.; Andersson, R. G. G. Angiotensin-Converting Enzyme Inhibitors and Their Inflammation, Bronchial Reactivity and Cough. Med. Toxicol. Adverse Drug Exp. 1989, 4, 369-380.
7. (a) Timmermans, P. B. M. W. M.; Wong, P. C.; Chiu, A. T.; Herbin, W. F. Nonpeptide Angiotensin II Receptor Antagonists. TIPS 1991, 12, 55-62.
8. (b) Hodges, J. C.; Hamby, J. M.; Blankley, C. J. Angiotensin II Receptor Binding Inhibitors. Drugs of the Future 1992, 17, 575-593.
9. (a) Wong, P. C.; Branes, B.; Chiu, A. T.; Christ, D.; Duncia, J. V.; Herblin, W. F.; Timmermans, P. B. M. W. M. Losartan (DuP 753), An Orally Active Nonpeptide Angiotensin II Receptor Antagonist. Cardiovasc. Drug Rev. 1991, 9, 317-339.
10. (b) Duncia, J. V.; Carini, D. J.; Chiu, A. T.; Johnson, A. L.; Price, W. A.; Wong, P. C.; Wexler, R. R.; Timmermans, P. B. M. W. M. The Discovery of DuP 753, a Potent, Orally Active Nonpeptide Angiotensin II Receptor Antagonist. Med. Res. Rev. 1992, 12, 149-191.
11. 1-Selective Angiotensin-II Receptor Antagonists. Bioorg. Med. Chem. Lett. 1993, 3, 1293-1298.
12. 1 Selective AII Antagonists. Bioorg. Med. Chem. Lett. 1993, 3, 1299-1304.
13. Carini, D. J.; Duncia, J. V.; Aldrich, P. E.; Chiu, A. T.; Johnson, A. L.; Pierce, M. E.; Sentella [1], J. B.; Wells, G. J.; Wexler, R. R.; Wong, P. C.; Yoo, S.-E.; Timmermams, P. B. M. W. M. Nonpeptide Angiotensin II Receptor Antagonists: The Discovery of a Series of N-(Biphenylylmethyl)imidazoles as Potent Orally Active Antihypertensives. J. Med. Chem. 1991, 34, 2525-2547.
14. Barker, B. R.; Almaular, P. I. Nonclassical Antimetabolites. X. A Facile Synthesis of 4-Quinazolone-2-carboxylic Acid and the Structure of Bogert's Ammonium Salt. J. Org. Chem. 1962, 27, 4672-4674.
15. Chern, J.-W; Chen, H.-T; Lai, N.-Y.; Wu, K.-R.; Chern, Y.-C. Studies on Quinazolines. VII. Reactions of Anthranilamide with β-Diketone; New Approaches toward the Synthesis of Tetrahydropyrido[2,1-b]quinazolin-11-one Derivatives. Chem. Pharm. Bull. 1998, 46, 928-933.
16. Chiu, A. T.; Carini, D. J.; Duncia, J. V.; Leung, K. H.; McCall, D. E.; Price, W. A.; Wong, P C.; Smith, R. D.; Wexler, R. R.; Chang, R. S.; Lotti, V. J. DuP 532: A Second Generation of Nonpeptide Angiotensin II Receptor Antagonists. Biochem. Biophys. Res. Commun. 1991, 177, 209-217.
17. 2 Receptors. Biochem. Biophys. Res. Comm. 1991, 181, 1365-1371.
18. Perrin, D. D.; Armarego, W. L. F. Purification of Laboratory Chemicals; Pergamon Press: Oxford, 1989.